Dashboard
Manage Tickers

ALLOAllogene Therapeutics, Inc.

Nasdaq allogene.com


$ 2.45 $ -0.21 (-7.89 %)    

Friday, 31-May-2024 12:04:17 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ -6.84 (-1.52 %)
DIA $ 398.57 $ -0.34 (-0.09 %)
SPY $ 530.36 $ -4.85 (-0.93 %)
TLT $ 91.26 $ -0.15 (-0.17 %)
GLD $ 225.37 $ -0.86 (-0.4 %)
$ 2.46
$ 2.66
$ 2.45 x 100
$ 2.46 x 200
$ 2.45 - $ 2.66
$ 2.23 - $ 6.05
3,599,354
na
416.06M
$ 1.02
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-14-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-02-2023 06-30-2023 10-Q
5 05-03-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-02-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-04-2022 03-31-2022 10-Q
10 02-23-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-05-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-04-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 08-07-2019 06-30-2019 10-Q
21 05-07-2019 03-31-2019 10-Q
22 03-08-2019 12-31-2018 10-K
23 11-21-2018 09-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

analyst-ratings-for-allogene-therapeutics
Analyst Ratings For Allogene Therapeutics
05/31/2024 12:00:17

piper-sandler-initiates-coverage-on-allogene-therapeutics-with-overweight-rating-announces-price-target-of-11
Piper Sandler Initiates Coverage On Alloge...
05/31/2024 09:53:54

Piper Sandler analyst Biren Amin initiates coverage on Allogene Therapeutics (NASDAQ:ALLO) with a Overweight rating and anno...

why-james-hardie-industries-shares-are-trading-lower-by-around-14-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why James Hardie Industries Shares Are Tra...
05/21/2024 17:36:28

why-larimar-therapeutics-shares-are-trading-higher-by-18-here-are-20-stocks-moving-premarket
Why Larimar Therapeutics Shares Are Tradin...
05/21/2024 12:12:19

oppenheimer-maintains-outperform-on-allogene-therapeutics-lowers-price-target-to-13
Oppenheimer Maintains Outperform on Alloge...
05/21/2024 12:00:55

Oppenheimer analyst Mark Breidenbach maintains Allogene Therapeutics (NASDAQ:ALLO) with a Outperform and lowers the price ta...

hc-wainwright--co-maintains-buy-on-allogene-therapeutics-lowers-price-target-to-9
HC Wainwright & Co. Maintains Buy on Allog...
05/16/2024 11:49:05

HC Wainwright & Co. analyst Robert Burns maintains Allogene Therapeutics (NASDAQ:ALLO) with a Buy and lowers the price t...

breaking-down-allogene-therapeutics-5-analysts-share-their-views
Breaking Down Allogene Therapeutics: 5 Ana...
05/15/2024 19:02:31

truist-securities-maintains-buy-on-allogene-therapeutics-maintains-17-price-target
Truist Securities Maintains Buy on Allogen...
05/15/2024 18:17:40

Truist Securities analyst Asthika Goonewardene maintains Allogene Therapeutics (NASDAQ:ALLO) with a Buy and maintains $17 pr...

why-arcutis-biotherapeutics-shares-are-trading-higher-by-29-here-are-20-stocks-moving-premarket
Why Arcutis Biotherapeutics Shares Are Tra...
05/15/2024 12:14:56

dlocal-allogene-therapeutics-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
DLocal, Allogene Therapeutics And Other Bi...
05/15/2024 10:12:21

allogene-therapeutics-files-for-offering-of-up-to-3793m-shares-of-common-stock
Allogene Therapeutics Files For Offering O...
05/14/2024 20:43:37

stifel-maintains-hold-on-allogene-therapeutics-raises-price-target-to-46
Stifel Maintains Hold on Allogene Therapeu...
05/14/2024 10:51:51

Stifel analyst Benjamin Burnett maintains Allogene Therapeutics (NASDAQ:ALLO) with a Hold and raises the price target from $...

allogene-therapeutics-prices-37931035-share-common-stock-offering-at-290share-gross-proceeds-110m
Allogene Therapeutics Prices 37,931,035 Sh...
05/13/2024 20:50:58

allogene-therapeutics-q1-2024-gaap-eps-038-beats-041-estimate-sales-22000k-down-from-30000k-yoy
Allogene Therapeutics Q1 2024 GAAP EPS $(0...
05/13/2024 20:06:36

Allogene Therapeutics (NASDAQ:ALLO) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
05/06/2024 12:06:38

allogene-therapeutics-awarded-15m-grant-from-california-institute-for-regenerative-medicine-to-advance-development-of-allogeneic-car-t-in-renal-cell-carcinoma
Allogene Therapeutics Awarded $15M Grant F...
04/26/2024 12:35:19

$15 million CIRM Grant Supports the Ongoing Phase 1 TRAVERSE Trial Evaluating ALLO-316 in Patients with Advanced or Metastatic ...

to-the-moon-a-look-inside-an-etf-focused-on-companies-at-the-cutting-edge-of-innovation
To The Moon! A Look Inside An ETF Focused ...
04/18/2024 18:29:09

hc-wainwright--co-reiterates-buy-on-allogene-therapeutics-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Allo...
03/19/2024 10:55:34

HC Wainwright & Co. analyst Robert Burns reiterates Allogene Therapeutics (NASDAQ:ALLO) with a Buy and maintains $10 pri...

rbc-capital-reiterates-outperform-on-allogene-therapeutics-maintains-10-price-target
RBC Capital Reiterates Outperform on Allog...
03/15/2024 16:19:26

RBC Capital analyst Luca Issi reiterates Allogene Therapeutics (NASDAQ:ALLO) with a Outperform and maintains $10 price target.

recap-allogene-therapeutics-q4-earnings
Recap: Allogene Therapeutics Q4 Earnings
03/14/2024 20:20:07

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION